wp-logo

On September 19, 2014, Horizon Pharma (NASDAQ: HZNP) completed the acquisition of Vidara Therapeutics. You will now be redirected to the ACTIMMUNE® (Interferon gamma-1b) page on Horizon Pharma’s corporate website.

If you are not redirected within 10 seconds, please click here.